Gilead Sciences Inc (GILD)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | |
| DSO | days | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
The analysis of Gilead Sciences Inc's days of sales outstanding (DSO) based on the provided data indicates that the DSO information is unavailable for the years ending on December 31, 2020, 2021, 2022, 2023, and 2024. Without specific DSO figures, it is challenging to assess the efficiency of Gilead Sciences Inc in collecting its accounts receivables in a timely manner. A lower DSO typically suggests a faster collection cycle and better liquidity position, while a higher DSO may indicate potential issues with accounts receivable management and cash flow. Due to the absence of DSO data, a detailed analysis of Gilead Sciences Inc's effectiveness in managing its receivables cannot be provided.
Peer comparison
Dec 31, 2024